NT Logo (WIPO, 10/15/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark NT was filed as Figurative mark on 10/15/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Quadrilaterals #Letters presenting a special form of writing #Colours #One quadrilateral #Quadrilaterals containing one or more letters #Quadrilaterals with dark surfaces or parts of surfaces #Monograms formed of intertwined, overlapping or otherwise combined letters #Letters in light-coloured characters on a dark background #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1626766 |
| Countries | 
|
| Base trademark |
No. 2214516,
September 29, 2021
|
| Application date | October 15, 2021 |
| Expiration date | October 15, 2031 |
Trademark owner
L 3 235 Pyrmont St
Pyrmont NSW 2009
AU
Pyrmont NSW 2009
AU
Trademark representatives
GPO Box 3810
Sydney NSW 2001
AU
goods and services
42
Clinical trials; conducting and managing clinical trials,
including clinical trials for pharmaceuticals, biotechnology
and other related industries; conducting clinical trials for
others (scientific research); providing information about
the results of clinical trials, including clinical trials
for pharmaceuticals and biotechnology; scientific research;
medical research (scientific research for medical purposes);
preparation of statistics for scientific research;
preparation of biostatistics for scientific research in the
fields of pharmaceuticals, biotechnology and other related
industries; provision of information and data relating to
medical and scientific research for pharmaceuticals,
biotechnology and other related industries; database design
and development services to process data collected from
clinical trials; medical research services, namely medical
monitoring services for research in the fields of
pharmaceuticals, biotechnology and other related industries;
quality audits; preparation of reports and applications to
regulators relating to aspects of clinical trials; provision
and exchange of information and data exchange between
scientists, manufacturers and health authorities relating to
pharmaceutical and biotechnology quality standards;
technical writing of clinical report forms which are
required by clinical trial drug protocols
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 19, 2023 | 2023/29 Gaz | GB | Rejection |
| May 19, 2023 | 2023/21 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 17, 2023 | 2023/21 Gaz | MY | Rejection |
| May 2, 2023 | 2023/18 Gaz | TH | Rejection |
| April 21, 2023 | 2023/18 Gaz | EM | Rejection |
| March 24, 2023 | 2023/14 Gaz | Correction | |
| January 26, 2023 | 2023/5 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| January 17, 2023 | 2023/6 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 14, 2022 | 2022/50 Gaz | KR | Rejection |
| November 16, 2022 | 2022/46 Gaz | VN | Rejection |
| September 24, 2022 | 2022/39 Gaz | ID | Rejection |
| August 25, 2022 | 2022/34 Gaz | JP | Rejection |
| August 19, 2022 | 2022/34 Gaz | US | Rejection |
| August 8, 2022 | 2022/32 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| July 11, 2022 | 2022/28 Gaz | IN | Rejection |
| June 28, 2022 | 2022/26 Gaz | NZ | Rejection |
| March 16, 2022 | 2022/11 Gaz | CN | Rejection |
| February 5, 2022 | 2022/7 Gaz | SG | Rejection |
| December 6, 2021 | 2021/50 Gaz | PH | Rejection |
| October 15, 2021 | 2021/44 Gaz | AU | Registration |
ID: 141626766